- Home
- PHAR vs CRSR Comparison
PHAR vs CRSR Comparison
Compare PHAR & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- CRSR
- Stock Information
- Founded
- PHAR 1988
- CRSR 1994
- Country
- PHAR Netherlands
- CRSR United States
- Employees
- PHAR N/A
- CRSR N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- CRSR Computer Manufacturing
- Sector
- PHAR Health Care
- CRSR Technology
- Exchange
- PHAR Nasdaq
- CRSR Nasdaq
- Market Cap
- PHAR 951.7M
- CRSR 986.3M
- IPO Year
- PHAR N/A
- CRSR 2020
- Fundamental
- Price
- PHAR $14.34
- CRSR $7.79
- Analyst Decision
- PHAR Strong Buy
- CRSR Buy
- Analyst Count
- PHAR 3
- CRSR 6
- Target Price
- PHAR $30.00
- CRSR $10.00
- AVG Volume (30 Days)
- PHAR 14.9K
- CRSR 822.8K
- Earning Date
- PHAR 10-23-2025
- CRSR 11-05-2025
- Dividend Yield
- PHAR N/A
- CRSR N/A
- EPS Growth
- PHAR N/A
- CRSR N/A
- EPS
- PHAR N/A
- CRSR N/A
- Revenue
- PHAR $339,836,000.00
- CRSR $1,407,684,000.00
- Revenue This Year
- PHAR $17.44
- CRSR $16.99
- Revenue Next Year
- PHAR $8.46
- CRSR $10.39
- P/E Ratio
- PHAR N/A
- CRSR N/A
- Revenue Growth
- PHAR 22.44
- CRSR 2.08
- 52 Week Low
- PHAR $7.31
- CRSR $5.64
- 52 Week High
- PHAR $17.08
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- PHAR 50.39
- CRSR 41.06
- Support Level
- PHAR $14.22
- CRSR $7.35
- Resistance Level
- PHAR $16.29
- CRSR $8.09
- Average True Range (ATR)
- PHAR 0.50
- CRSR 0.38
- MACD
- PHAR -0.13
- CRSR -0.08
- Stochastic Oscillator
- PHAR 37.30
- CRSR 30.76
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.